Cargando…
EGFR alterations in glioblastoma play a role in antitumor immunity regulation
The epidermal growth factor receptor (EGFR) is the most frequently altered gene in glioblastoma (GBM), which plays an important role in tumor development and anti-tumor immune response. While current molecular targeted therapies against the EGFR signaling pathway and its downstream key molecules hav...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436475/ https://www.ncbi.nlm.nih.gov/pubmed/37601668 http://dx.doi.org/10.3389/fonc.2023.1236246 |